LIBRE LIFE LATEST NEWS

A new CGM launches this February in the UK.

News that Abbott and Dexcom have agreed not to sue each other for patents relating to their CGM tech for another 10 years. 

Sana Biotechnology announce a significant step in the use of islet cells for T1D treatment that could pave the way to a T1D 'cure'!

How 2 London hospitals are trialling use of AI to detect early signs of type 2 diabetes which could be rolled out across the UK by the NHS.

Insulet win case against EO Flow insulin patch pump design.

News that Sanofi made its largest investment in China with new insulin manufacturing in Beijing.

Abbott announces new manufacturing facility in Ireland to address Libre 3 demand.

Following FDA clearance, Embecta will no longer pursue plans for a patch pump.

Medtronic announce they will roll out their latest Simplera CGM in the US.

News that Tandem t:slim X2 insulin pump is now cleared for use with Lyumjev.